๐Ÿ“‹ SMCI appears undervalued at ~$12B market cap despite poor optics

medium convictionFirst mentioned Sep 9, 2025

SMCI appears undervalued at ~$12B market cap despite poor optics.

Evidence & details
Evidence
  • +PENG builds a 2U box inside the rack around Celestial/Marvell's photonic memory IP.
  • +It is at the development collaboration stage, not even in qualification stage.
  • +High-margin foundational IP belongs to companies like Celestial or Lightmatter, not PENG.
Risks
  • โˆ’Retail misunderstanding of the different layers and conflation of PENG as core IP developer.
  • โˆ’Upside would require passing sampling stage, which is uncertain.

Chart

Post Timeline ยท 1 posts

risk signalhigh

Very nuanced. People buying $PENG for $MRVL "photonic memory" are likely to be disappointed. They're on the $SMCI integrator level with potential software add. The high margin, foundational IP belongs to companies like Celestial or others like Lightmatter. What they do is buiโ€ฆ

Thesis: PENG is not the core photonic memory IP owner; it is an integrator building a chassis around Celestial/Marvell's IP, and the development is at an early stage. Investors conflating PENG with MRVL's phoโ€ฆ

Current Price
$41.30
via cornerstones
Return from entry
โ€”
entry Sep 9, 2025
Thesis Lifecycle
๐Ÿ“
updatedOct 19, 2025

Author presents a comprehensive trading plan for rate cut week, recommending longs in neocloud, semiconductors, and select other stocks while selling overvalued quantum, space, and crypto assets. Key macro view: market fear is an ideal entry point ahead of expected rate cut.

source โ†—
๐Ÿ“
updatedNov 12, 2025

The user is heavily adding to neocloud positions (NBIS, IREN, CIFR, CORZ, SMCI) believing the sector is oversold. NBIS has strong fundamentals with $8B forward ARR and 30% EBITDA margin target.

source โ†—
๐Ÿ“
updatedNov 20, 2025

The author presents detailed bullish investment theses for nine stocks across AI infrastructure, space, fintech, and healthcare, citing specific catalysts and price targets based on fundamental analysis.

source โ†—
๐Ÿ“
updatedDec 2, 2025

SMCI is undervalued due to temporary margin compression and delayed orders; with raised FY guidance and expected margin recovery, it trades at low P/E with 60% growth.

source โ†—
๐Ÿ“
updatedDec 2, 2025-1 conv

SMCI and DELL are beneficiaries of massive data center build-out; market is huge and both are poised to do well.

source โ†—
๐Ÿ“
updatedDec 2, 2025+1 conv

SMCI's forward revenue growth from $22B to $36B in one year with ~11 forward P/E is extremely good value, driven by AI capex and DC expansion.

source โ†—
๐Ÿ“
updatedDec 2, 2025-1 conv

Comparative analysis: NBIS offers high-beta hyper growth with potential from robotaxi subsidiary; SMCI is a value play with 60% Y/Y growth at 11x forward P/E, mispriced relative to sector.

source โ†—
๐Ÿ“
updatedDec 8, 2025

Bullish updates for LITE (benefits from NVDA Blackwell and GOOGL TPU rampup), AMKR (benefits from US fab policy with TSM), and SMCI (strong revenue growth, recent drop unwarranted).

source โ†—
๐Ÿ“
updatedDec 8, 2025+1 conv

SMCI is bound for a recovery due to forward revenue backlog in Q2 2026.

source โ†—
๐Ÿ“
updatedDec 10, 2025

Post-Fed rate cut analysis provides stock ratings with explanations: Strong Buy on stablecoin, semi, and growth plays; Buy on AI infrastructure and select recovery plays; Avoid on overvalued or fundamental-less stocks.

source โ†—
๐Ÿ“
updatedDec 31, 2025

The January Effect is expected to cause mean reversion rallies in beaten-down stocks with strong forward earnings, including MSTR, HIMS, SMCI, SNAP, and MRVL due to end-of-year tax loss harvesting.

source โ†—
๐Ÿ“
updatedDec 31, 2025

These stocks are oversold and have strong fundamentals, making them candidates for mean reversion rallies.

source โ†—
๐Ÿ“
updatedJan 2, 2026+1 conv

A comprehensive set of stock ratings for 2026, focusing on recovery plays from tax-loss harvesting and sector tailwinds in AI, semiconductors, data centers, and defense, while avoiding overvalued quantum and retail names.

source โ†—
๐Ÿ“
updatedJan 2, 2026

SMCI is undervalued due to temporary backlog delays and transitory margin compression; strong revenue growth, low PEG, sovereign AI opportunity, and low P/S make it a good swing trade near 1-year low.

source โ†—
๐Ÿ“
updatedJan 13, 2026

SMCI is mispriced because analysts underestimate margin expansion over DLC cycles; near-term margin compression is temporary and margins will expand over time, supported by raised revenue guidance to $36B for 2026.

source โ†—
๐Ÿ“
updatedJan 24, 2026

Personal stock ratings with detailed commentary: Strong Buy on 14 stocks (SNAP, META, MU, TSM, etc.) citing catalysts like memory supercycle, bottlenecks, and AI tailwinds. Buy on 32 stocks including COIN, SMCI, GOOGL, and several crypto and drone plays. Questionable on VELO and SKYT due to weak fundamentals. Avoid on 11 stocks (UAVS, BKKT, PLTR, etc.) due to dilution, high debt, or overvaluation. Overall bullish on AI, memory, bottlenecks, made-in-America supply chains, and defense, with a long-term view until after midterms.

source โ†—
๐Ÿ“
updatedMar 20, 2026

SMCI at ~$14B market cap (near $24) may be a buying opportunity as GAAP net income is ~$1.05B and FY2026 estimates ~$1.25B, even after subtracting ~$150M from smuggled profits, implying ~10-11x forward P/E. Risks include regulatory optics, potential DOJ action, and NVDA distancing, but some China revenue was already priced in.

source โ†—
๐Ÿ“
updatedMar 20, 2026+1 conv

Believes $13B valuation for SMCI is a buying opportunity with fundamental floor around $10B.

source โ†—
๐Ÿ“
updatedMar 22, 2026-1 conv

SMCI appears undervalued at ~$12B market cap despite poor optics.

source โ†—
๐Ÿ’ค
dormantMay 29, 2026

No qualifying thesis event for 45+ days.